Advanced search
Publication Cover
Leukemia & Lymphoma Volume 57, 2016 - Issue 2
Submit an article Journal homepage
166
Views
4
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Survival of de novo and secondary acute promyelocytic leukemia: a propensity-matched analysis of the SEER database

Smith GiriDepartment of Medicine, University of Tennessee Health Science Center, Memphis, TN, USA
,
Ranjan PathakDepartment of Medicine, Reading Health System, Reading, PA, USA
,
Mike G. MartinDepartment of Medicine, University of Tennessee Health Science Center, Memphis, TN, USA
&
Vijaya Raj BhattUniversity of Nebraska Medical Center, Department of Internal Medicine, Division of Hematology-Oncology, Omaha, Nebraska, USACorrespondence[email protected]
Pages 385-391 | Received 01 Feb 2015, Accepted 13 Jun 2015, Published online: 25 Jul 2015

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Ziren Chen, Wei Mai, Zhengxiong Li, Haoyang Zhang, Yu Zheng, Shunrong Hong, Wencong Yang, Weiliang Xiao, Zhilin Chen & Shuncong Wang. (2019) The epidemiological trend of acute promyelocytic leukemia over past four decades: a population-based analysis. Leukemia & Lymphoma 60:14, pages 3470-3481.
Read now

Articles from other publishers (3)

Prajwal Dhakal, Bimatshu Pyakuryal, Prasun Pudasainee, Venkat Rajasurya, Krishna Gundabolu & Vijaya Raj Bhatt. (2020) Treatment Strategies for Therapy-related Acute Myeloid Leukemia. Clinical Lymphoma Myeloma and Leukemia 20:3, pages 147-155.
Crossref
Chong Chyn Chua, Shaun Fleming & Andrew H. Wei. (2019) Clinicopathological aspects of therapy-related acute myeloid leukemia and myelodysplastic syndrome. Best Practice & Research Clinical Haematology 32:1, pages 3-12.
Crossref
Rajesh Shrestha, Smith Giri, Ranjan Pathak & Vijaya Raj Bhatt. (2016) Risk of second primary malignancies in a population-based study of adult patients with essential thrombocythemia. World Journal of Clinical Oncology 7:4, pages 324.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.